Status:

COMPLETED

A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Lead Sponsor:

Ferring Pharmaceuticals

Conditions:

Prostate Cancer

Eligibility:

MALE

20+ years

Phase:

PHASE3

Brief Summary

A phase III trial investigating the efficacy and safety of degarelix one-month depot in Taiwanese patients with prostate cancer.

Eligibility Criteria

Inclusion

  • 20 years or older
  • Has a histological confirmed prostate cancer
  • Has a screening serum testosterone above 1.5 ng/mL
  • Has a Eastern Cooperative Oncology Group (ECOG) score of ≤ 2
  • Has a screening PSA value of ≥2 ng/mL
  • Has a life expectancy of at least 168 days

Exclusion

  • Current or previous hormone therapy
  • Is currently treated with 5-α-reductase inhibitor
  • Has a history of severe untreated asthma, anaphylactic reactions, or severe urticaria and/or angioedema
  • Is considered to be a candidate for curative therapy, i.e radical prostatectomy or radiotherapy
  • Has had cancer within the last five years except prostate cancer and surgically removed basal or squamous cell carcinoma of the skin.
  • Has a clinically significant disorder (other than prostate cancer) or any other condition , including alcohol or drug abuse, which may interfere with trial participation or which may affect the conclusion of the trial as judged by the investigator
  • Has received an investigational drug within the last 28 days preceding Screening Visit or longer if considered to possibly influence the outcome of the current trial

Key Trial Info

Start Date :

December 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2012

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT01220869

Start Date

December 1 2010

End Date

October 1 2012

Last Update

April 13 2025

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Changhua Christian Hospital

Changhua, Taiwan

2

Chang Gung Medical Foundation, Chiayi Branch

Chiayi City, Taiwan

3

Chang Gung Memorial Hospital, Kaohsiung

Kaohsiung City, Taiwan

4

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

A Study of Degarelix in Taiwanese Patients With Prostate Cancer | DecenTrialz